About aTTP/iTTP CABLIVI (caplacizumab-yhdp)

CABLIVI (caplacizumab-yhdp) MOA for HCPs

Figure 1, Model Structure — Decision Tree, Acute aTTP Episode - Caplacizumab (Cablivi) - NCBI Bookshelf

Caplacizumab: Uses, Interactions, Mechanism of Action

These highlights do not include all the information needed to use CABLIVI® safely and effectively. See full prescribing information for CABLIVI. CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use Initial U.S.

Caplacizumab-yhdp (Cablivi): the first therapy for the treatment of aTTP

Understanding aTTP

A Rare Blood Disorder, aTTP, Can Start With a Simple Symptom — But It Can Be Life-Threatening - HealthyWomen

Sanofi Promise Warranty Program for Cablivi® (caplacizumab-yhdp) Seeks to Help Support Physicians Managing aTTP

Cablivi (caplacizumab) for acquired thrombotic thrombocytopenic purpura

About aTTP/iTTP CABLIVI (caplacizumab-yhdp)

Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis - ScienceDirect

CABLIVI (caplacizumab-yhdp) Coverage and Reimbursement

TTP Communities CABLIVI (caplacizumab-yhdp)

Cablivi (Caplacizumab-yhdp Injection): Side Effects, Uses, Dosage, Interactions, Warnings

Caplacizumab - wikidoc